Several other analysts have also recently commented on CSRT. Panmure Gordon restated a buy rating and issued a GBX 1,145 ($14.95) target price on shares of Consort Medical plc in a research note on Thursday, June 9th. Investec increased their price target on shares of Consort Medical plc from GBX 1,150 ($15.01) to GBX 1,170 ($15.27) and gave the company a buy rating in a report on Thursday, June 16th. Stifel Nicolaus reiterated a buy rating and issued a GBX 1,200 ($15.66) price target on shares of Consort Medical plc in a report on Thursday, June 16th. Finally, Numis Securities Ltd reiterated an under review rating on shares of Consort Medical plc in a report on Friday, June 17th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Consort Medical plc currently has an average rating of Buy and an average price target of GBX 1,149.67 ($15.01).
Consort Medical plc (LON:CSRT) opened at 1075.5236 on Tuesday. Consort Medical plc has a 52-week low of GBX 904.20 and a 52-week high of GBX 1,155.00. The company’s 50-day moving average is GBX 1,037.15 and its 200-day moving average is GBX 1,017.69. The firm’s market capitalization is GBX 525.17 million.
In other Consort Medical plc news, insider Cotton,Richard bought 1,382 shares of the company’s stock in a transaction on Monday, September 5th. The stock was purchased at an average cost of GBX 651 ($8.50) per share, for a total transaction of £8,996.82 ($11,743.66).
About Consort Medical plc
Consort Medical plc is a contract development and manufacturing organization (CDMO). The Company is engaged in providing delivery technologies, formulation and manufacturing solutions for drugs. The Company operates through two divisions: Bespak and Aesica. The Bespak division develops and manufactures drug delivery devices to deliver drugs to sufferers of asthma and chronic obstructive pulmonary disease (COPD).
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.